Great Lakes Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
Great Lakes Advisors's CDLX Position: Q3 2021 in Review
Great Lakes Advisors sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 324 shares — an estimated $412K sold.
Great Lakes Advisors first reported a position in CDLX in Q2 2020 and held it in 5 quarters. The position peaked at $32.3M in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.
- Great Lakes Advisors reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
- Great Lakes Advisors sold 324 Cardlytics shares in Q3 2021, an estimated $412K.
- Great Lakes Advisors first reported a position in Cardlytics in Q2 2020 and held it in 5 quarters.
- Great Lakes Advisors's Cardlytics position peaked at $32.3M in Q4 2020.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.
Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.